Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

被引：589

作者：

Inzucchi, Silvio E. ^{[1
]}

Bergenstal, Richard M. ^{[2
]}

Buse, John B. ^{[3
]}

Diamant, Michaela ^{[4
]}

Ferrannini, Ele ^{[5
]}

Nauck, Michael ^{[6
]}

Peters, Anne L. ^{[7
]}

Tsapas, Apostolos ^{[8
]}

Wender, Richard ^{[9
,10
]}

Matthews, David R. ^{[11
,12
,13
]}

机构：

[1] Yale Univ, Sch Med, Endocrinol Sect, Yale New Haven Hosp, New Haven, CT USA

[2] Pk Nicollet, Int Diabet Ctr, Minneapolis, MN USA

[3] Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC USA

[4] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Ctr Diabet, Amsterdam, Netherlands

[5] Univ Pisa, Sch Med, Dept Med, I-56100 Pisa, Italy

[6] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany

[7] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA

[8] Aristotle Univ Thessaloniki, Dept Med 2, GR-54006 Thessaloniki, Greece

[9] Amer Canc Soc, Atlanta, GA 30329 USA

[10] Thomas Jefferson Univ, Jefferson Med Coll, Dept Family & Community Med, Philadelphia, PA 19107 USA

[11] Univ Oxford, Harris Manchester Coll, Oxford OX1 3TD, England

[12] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England

[13] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England

来源：

DIABETOLOGIA | 2015年 / 58卷 / 03期

关键词：

Guidelines; Insulin; Oral agents; Therapy; Type; 2; diabetes; INADEQUATE GLYCEMIC CONTROL; INTENSIVE INSULIN THERAPY; BASAL INSULIN; DOUBLE-BLIND; COMBINATION THERAPY; PIOGLITAZONE USE; SGLT2; INHIBITOR; GLUCOSE CONTROL; CLINICAL-TRIAL; FOLLOW-UP;

D O I：

10.1007/s00125-014-3460-0

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：429 / 442

页数：14

共 61 条

[1]

[Anonymous], 2009, TYP 2 DIAB MAN TYP 2

[2]

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications [J].

Bakris, George L. ;

Fonseca, Vivian A. ;

Sharma, Kumar ;

Wright, Ernest M. .

KIDNEY INTERNATIONAL, 2009, 75 (12) :1272-1277

[3]

Balaji V, 2014, Indian J Endocrinol Metab, V18, P425, DOI 10.4103/2230-8210.131223

[4]

Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature [J].

Balena, R. ;

Hensley, I. E. ;

Miller, S. ;

Barnett, A. H. .

DIABETES OBESITY & METABOLISM, 2013, 15 (06) :485-502

[5]

Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study [J].

Bosi, E. ;

Ellis, G. C. ;

Wilson, C. A. ;

Fleck, P. R. .

DIABETES OBESITY & METABOLISM, 2011, 13 (12) :1088-1096

[6]

Use of Twice-Daily Exenatide in Basal Insulin-Treated Patients With Type 2 Diabetes A Randomized, Controlled Trial [J].

Buse, John B. ;

Bergenstal, Richard M. ;

Glass, Leonard C. ;

Heilmann, Cory R. ;

Lewis, Michelle S. ;

Kwan, Anita Y. M. ;

Hoogwerf, Byron J. ;

Rosenstock, Julio .

ANNALS OF INTERNAL MEDICINE, 2011, 154 (02) :103-+

[7]

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial [J].

Cefalu, William T. ;

Leiter, Lawrence A. ;

Yoon, Kun-Ho ;

Arias, Pablo ;

Niskanen, Leo ;

Xie, John ;

Balis, Dainius A. ;

Canovatchel, William ;

Meininger, Gary .

LANCET, 2013, 382 (9896) :941-950

[8]

Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis [J].

Charbonnel, Bernard ;

Bertolini, Monica ;

Tinahones, Francisco J. ;

Puig Domingo, Manuel ;

Davies, Melanie .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) :880-886

[9]

Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19) [J].

Charbonnel, Bernard ;

DeFronzo, Ralph ;

Davidson, Jaime ;

Schmitz, Ole ;

Birkeland, Kare ;

Pirags, Valdis ;

Scheen, Andre .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) :2163-2171

[10]

The STOP-NIDDM Trial -: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance:: rationale, design, and preliminary screening data [J].

Chiasson, JL ;

Gomis, R ;

Hanefeld, M ;

Josse, RG ;

Karasik, A ;

Laakso, M .

DIABETES CARE, 1998, 21 (10) :1720-1725

← 1 2 3 4 5 6 7 →